Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2026
Dosimetric parameters of the axillary-lateral thoracic junction in predicting risk of breast cancer-related lymphedema.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Hong Soon Woo, Kim Eun-Kyu, Shin Hee-Chul, Beom Jaewon, Lim Jae-Young, Kim In Ah, Kim Kyubo
Аннотация
INTRODUCTION: Regional nodal irradiation (RNI) is associated with breast cancer-related lymphedema (BCRL), yet varying definition of extensive RNI among radiation oncologists leads to the inconsistencies in risk assessment. Recently, the axillary-lateral thoracic junction (ALTJ) has been proposed as a potential organ-of-interest, but its role remains controversial. This study investigates the predictive role of ALTJ dose-volumetric parameters in BCRL development.
METHODS AND MATERIALS: We identified patients with breast cancer who underwent surgery and adjuvant radiotherapy (2018 - 2020). BCRL was defined as newly developed upper arm lymphedema after radiotherapy, with International Society of Lymphology stage ≥ 2. Following retrospective ALTJ contouring, multivariable Cox regression and Random Survival Forest models were developed using clinical factors and ALTJ dosimetric parameters. Model performance was evaluated via Harrell's C-index and 24-month landmark analysis.
RESULTS: We investigated 722 patients with a median follow-up of 30 months. 283 (39.2%) underwent axillary lymph node dissection (ALND). In multivariate Cox regression, along with ALND, ALTJ V35Gy > 50% was associated with an increased risk BCRL (p = 0.003, HR 3.07), whereas binary RNI status wasn't (p = 0.363). When comparing multivariable prognostic frameworks, Model B (incorporating ALTJ V35Gy) demonstrated a more favorable statistical fit than Model A (incorporating RNI). While Model B yielded a numerically higher C-index (0.753 vs. 0.749), this gain was not statistically significant.
CONCLUSIONS: This study highlights the significance of the ALTJ as an organ-of-interest in breast cancer patients who underwent radiotherapy. Incorporating ALTJ dosimetric parameters into predictive models enhances prognostic accuracy, addressing the limitations of variable RNI field definitions.
METHODS AND MATERIALS: We identified patients with breast cancer who underwent surgery and adjuvant radiotherapy (2018 - 2020). BCRL was defined as newly developed upper arm lymphedema after radiotherapy, with International Society of Lymphology stage ≥ 2. Following retrospective ALTJ contouring, multivariable Cox regression and Random Survival Forest models were developed using clinical factors and ALTJ dosimetric parameters. Model performance was evaluated via Harrell's C-index and 24-month landmark analysis.
RESULTS: We investigated 722 patients with a median follow-up of 30 months. 283 (39.2%) underwent axillary lymph node dissection (ALND). In multivariate Cox regression, along with ALND, ALTJ V35Gy > 50% was associated with an increased risk BCRL (p = 0.003, HR 3.07), whereas binary RNI status wasn't (p = 0.363). When comparing multivariable prognostic frameworks, Model B (incorporating ALTJ V35Gy) demonstrated a more favorable statistical fit than Model A (incorporating RNI). While Model B yielded a numerically higher C-index (0.753 vs. 0.749), this gain was not statistically significant.
CONCLUSIONS: This study highlights the significance of the ALTJ as an organ-of-interest in breast cancer patients who underwent radiotherapy. Incorporating ALTJ dosimetric parameters into predictive models enhances prognostic accuracy, addressing the limitations of variable RNI field definitions.